Panbela Therapeutics, Inc. (NASDAQ: PBLA) reported Q3 EPS of ($0.21), $0.02 better than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Panbela Therapeutics, Inc. (PBLA) click here.